Showing information for "lysophosphatidylcholine acyl C26:1"


Metabolite information

HMDB ID -
Synonyms
-
Chemical formula -
IUPAC name
-
CAS registry number -
Monoisotopic molecular weight -

Chemical taxonomy

Super class -
Class -
Sub class -

Biological properties

Pathways
-

The studies that identify "lysophosphatidylcholine acyl C26:1" as a lung cancer-related metabolite

The studies that identify "lysophosphatidylcholine acyl C26:1" as a lung cancer-related metabolite


Reference Country Specimen Marker function Participants (Case) Participants (Control)
Cancer type Stage Number Gender (M,F) Age mean (range) (M/F) Smoking status Type Number Gender (M,F) Age mean (range) (M/F) Smoking status
Klupczynska et al. 2019 Poland serum diagnosis adenocarcinoma, squamous cell carcinoma I 20 11, 9 62 ± 5 smoker, non-smoker noncancerous lung diseases 20 8, 16 63 ± 6 smoker, non-smoker
Reference Chromatography Ion source Positive/Negative mode Mass analyzer Identification level
Klupczynska et al. 2019 flow infusion QTRAP MS/MS
Reference Data processing software Database search
Klupczynska et al. 2019 Analyst
Reference Difference method Mean concentration (case) Mean concentration (control) Fold change (case/control) P-value FDR VIP
Klupczynska et al. 2019 Wilcoxon rank-sum test 0.28 ± 0.07 0.18 ± 0.06 1.52 8.30e-04 0.04
Reference Classification method Cutoff value AUROC 95%CI Sensitivity (%) Specificity (%) Accuracy (%)
Klupczynska et al. 2019 ROC analysis 0.84 (0.68-0.95)